SCHEDULE 13G

Company

Eloxx Pharmaceuticals, Inc.

Filed

June 14, 2021

Accession Number

0001104659-21-080752

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →